These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27570581)

  • 1. The effect of aliskiren on the renal dysfunction following unilateral ureteral obstruction in the rat.
    Hammad FT; Lubbad L
    Int J Physiol Pathophysiol Pharmacol; 2016; 8(2):70-7. PubMed ID: 27570581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of epigallocatechin-3-gallate on the renal dysfunction in the obstructed kidney in the rat.
    Hammad FT; Lubbad L
    Int J Physiol Pathophysiol Pharmacol; 2017; 9(4):119-126. PubMed ID: 28951774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does aliskiren protect the kidney following ischemia reperfusion injury?
    Hammad FT; Al-Salam S; Lubbad L
    Physiol Res; 2013; 62(6):681-90. PubMed ID: 23869885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Arabic Gum on Renal Function in Reversible Unilateral Ureteric Obstruction.
    Hammad FT; Salam SA; Nemmar A; Ali M; Lubbad L
    Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30641998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
    Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
    Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.
    Hammad FT; Lubbad L
    Int J Physiol Pathophysiol Pharmacol; 2016; 8(4):152-159. PubMed ID: 28078054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diclofenac sodium on renal function in reversible unilateral ureteric obstruction.
    Hammad FT; Lubbad L
    Urol Res; 2011 Oct; 39(5):351-6. PubMed ID: 21190019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aliskiren restores renal AQP2 expression during unilateral ureteral obstruction by inhibiting the inflammasome.
    Wang W; Luo R; Lin Y; Wang F; Zheng P; Levi M; Yang T; Li C
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F910-22. PubMed ID: 25694485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.
    Sakuraya K; Endo A; Someya T; Hirano D; Murano Y; Fujinaga S; Ohtomo Y; Shimizu T
    J Urol; 2014 Apr; 191(4):1139-46. PubMed ID: 24140549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aliskiren ameliorates renal inflammation and fibrosis induced by unilateral ureteral obstruction in mice.
    Choi DE; Jeong JY; Lim BJ; Chang YK; Na KR; Shin YT; Lee KW
    J Urol; 2011 Aug; 186(2):694-701. PubMed ID: 21683401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Hypertension on the Recovery of Renal Dysfunction following Reversal of Unilateral Ureteral Obstruction in the Rat.
    Hammad FT; Lubbad L; Al-Salam S; Yasin J; Meeran MFN; Ojha S; Hammad WF
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model.
    Tiradentes RV; Santuzzi CH; Claudio ER; Mengal V; Silva NF; Neto HA; Bissoli NS; Abreu GR; Gouvea SA
    Hypertens Res; 2015 Jul; 38(7):471-7. PubMed ID: 25740291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of diabetes mellitus on the recovery of changes in renal functions and glomerular permeability following reversible 24-hour unilateral ureteral obstruction.
    Bakoush O; Lubbad L; Öberg CM; Hammad FT
    J Diabetes; 2019 Aug; 11(8):674-683. PubMed ID: 30592154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term renal effects of unilateral ureteral obstruction and the role of endothelin.
    Hammad FT; Wheatley AM; Davis G
    Kidney Int; 2000 Jul; 58(1):242-50. PubMed ID: 10886569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren.
    Wu WP; Chang CH; Chiu YT; Ku CL; Wen MC; Shu KH; Wu MJ
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F929-41. PubMed ID: 20685818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice.
    Chung S; Jeong JY; Chang YK; Choi DE; Na KR; Lim BJ; Lee KW
    Korean J Intern Med; 2016 Mar; 31(2):323-34. PubMed ID: 26932402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candesartan prevents long-term impairment of renal function in response to neonatal partial unilateral ureteral obstruction.
    Topcu SO; Pedersen M; Nørregaard R; Wang G; Knepper M; Djurhuus JC; Nielsen S; Jørgensen TM; Frøkiaer J
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F736-48. PubMed ID: 17032940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alda-1, an aldehyde dehydrogenase-2 agonist, causes deterioration in renal functions following ischemia-reperfusion injury due to crystalline nephropathy.
    Hammad FT; Al-Salam S; Yuvaraju P; Lubbad L
    Drug Dev Res; 2018 Nov; 79(7):315-323. PubMed ID: 30291750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment combining aliskiren with paricalcitol is effective against progressive renal tubulointerstitial fibrosis via dual blockade of intrarenal renin.
    Chung S; Kim S; Kim M; Koh ES; Shin SJ; Park CW; Chang YS; Kim HS
    PLoS One; 2017; 12(7):e0181757. PubMed ID: 28753620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
    Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
    Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.